Metformin exerts synergistic anti-proliferative effects with liraglutide in human umbilical vein endothelial cells (HUVECs)

Shadboorestan, A; Eftekhari, S; Mottaghi-Dastjerdi, N; Shahparvari, R; Tarighi, P; Jahandar, H; Faghihi, H; Montazeri, H

Montazeri, H (通讯作者),Iran Univ Med Sci, Sch Pharm, Dept Pharmacognosy & Pharmaceut Biotechnol, Tehran, Iran.

IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022; 25 (4): 506

Abstract

Objective(s): Metformin (Met) and liraglutide (Lira) have been approved to treat type 2 diabetes mellitus and have cardioprotective effects. Materials......

Full Text Link